Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Reviva Pharmaceuticals Holdings, Inc. (RVPH) had Debt to Equity Ratio of 0.01 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-2.45M |
|
-- |
|
-- |
|
$2.62M |
|
$-2.62M |
|
$0.17M |
|
$-2.45M |
|
$-2.45M |
|
$-2.45M |
|
$-2.45M |
|
$-2.45M |
|
$-2.45M |
|
$-2.62M |
|
$-2.62M |
|
13.21M |
|
13.21M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$21.14M |
|
-- |
|
-- |
|
$21.14M |
|
$5.93M |
|
-- |
|
-- |
|
$5.93M |
|
$15.21M |
|
$15.21M |
|
$15.21M |
|
13.11M |
|
| Cash Flow Statement Financials | |
$-5.92M |
|
-- |
|
$11.37M |
|
$14.44M |
|
$19.89M |
|
$5.45M |
|
$0.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.56 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
0.01 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.92M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-16.10% |
|
-16.10% |
|
-11.58% |
|
-16.10% |
|
$1.16 |
|
$-0.45 |
|
$-0.45 |
|